Ascelia Pharma AB

OSTO:ACE (Sweden)  
kr 8.05 (+4.55%) Feb 29
At Loss
P/B:
3.21
Market Cap:
kr 259.94M ($ 26.21M)
Enterprise V:
kr 222.21M ($ 22.57M)
Volume:
127.16K
Avg Vol (2M):
381.30K
Also Trade In:
Volume:
127.16K
At Loss
Avg Vol (2M):
381.30K

Business Description

Description
Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo, Sweden, focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. The company is focused on two clinical-stage product candidates under development: Mangoral and Oncoral.
Name Current Vs Industry Vs History
Cash-To-Debt 30.8
Equity-to-Asset 0.8
Debt-to-Equity 0.02
Debt-to-EBITDA -0.01
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 57.19
9-Day RSI 51.54
14-Day RSI 52.6
6-1 Month Momentum % 98.81
12-1 Month Momentum % -49.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.24
Quick Ratio 2.24
Cash Ratio 1.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.8
Shareholder Yield % -0.07

Financials (Next Earnings Date:2024-05-16)

OSTO:ACE's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Ascelia Pharma AB Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr)
EPS (TTM) (kr) -4.41
Beta 0
Volatility % 177.02
14-Day RSI 52.6
14-Day ATR (kr) 0.828224
20-Day SMA (kr) 8.274
12-1 Month Momentum % -49.14
52-Week Range (kr) 2.62 - 17.5
Shares Outstanding (Mil) 33.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ascelia Pharma AB Filings

Filing Date Document Date Form
No Filing Data

Ascelia Pharma AB Stock Events

Financials Calendars
Event Date Price(kr)
No Event Data

Ascelia Pharma AB Frequently Asked Questions

What is Ascelia Pharma AB(OSTO:ACE)'s stock price today?
The current price of OSTO:ACE is kr8.05. The 52 week high of OSTO:ACE is kr17.50 and 52 week low is kr2.62.
When is next earnings date of Ascelia Pharma AB(OSTO:ACE)?
The next earnings date of Ascelia Pharma AB(OSTO:ACE) is 2024-05-16.
Does Ascelia Pharma AB(OSTO:ACE) pay dividends? If so, how much?
Ascelia Pharma AB(OSTO:ACE) does not pay dividend.

Press Release

Subject Date
No Press Release